- Home
- ABEO vs ARQ Comparison
ABEO vs ARQ Comparison
Compare ABEO & ARQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- ARQ
- Stock Information
- Founded
- ABEO N/A
- ARQ 1996
- Country
- ABEO United States
- ARQ United States
- Employees
- ABEO N/A
- ARQ N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- ARQ
- Sector
- ABEO Health Care
- ARQ
- Exchange
- ABEO Nasdaq
- ARQ NYSE
- Market Cap
- ABEO 243.9M
- ARQ 249.0M
- IPO Year
- ABEO 1980
- ARQ N/A
- Fundamental
- Price
- ABEO $6.41
- ARQ $5.41
- Analyst Decision
- ABEO Strong Buy
- ARQ
- Analyst Count
- ABEO 3
- ARQ 0
- Target Price
- ABEO $18.00
- ARQ N/A
- AVG Volume (30 Days)
- ABEO 287.3K
- ARQ 378.8K
- Earning Date
- ABEO 11-11-2024
- ARQ 08-12-2024
- Dividend Yield
- ABEO N/A
- ARQ N/A
- EPS Growth
- ABEO N/A
- ARQ N/A
- EPS
- ABEO N/A
- ARQ N/A
- Revenue
- ABEO N/A
- ARQ $105,078,000.00
- Revenue This Year
- ABEO N/A
- ARQ $4.58
- Revenue Next Year
- ABEO $7,097.06
- ARQ $40.31
- P/E Ratio
- ABEO N/A
- ARQ N/A
- Revenue Growth
- ABEO 147.52
- ARQ 12.87
- 52 Week Low
- ABEO $3.05
- ARQ $1.60
- 52 Week High
- ABEO $9.01
- ARQ $8.26
- Technical
- Relative Strength Index (RSI)
- ABEO 61.15
- ARQ 44.03
- Support Level
- ABEO $6.39
- ARQ $5.12
- Resistance Level
- ABEO $6.74
- ARQ $5.78
- Average True Range (ATR)
- ABEO 0.31
- ARQ 0.32
- MACD
- ABEO 0.02
- ARQ -0.02
- Stochastic Oscillator
- ABEO 68.57
- ARQ 26.32
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granular Activated Carbon, and Colloidal Carbon Product among others.